The role of vitamin D in pediatric systemic lupus erythematosus - a double pawn in the immune and microbial balance.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 20 01 2024
accepted: 08 04 2024
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 8 5 2024
Statut: epublish

Résumé

Having increased popularity during the Covid-19 pandemic, vitamin D3 is currently impressing thanks to the numerous researches aimed at its interactions with the body's homeostasis. At the same time, there is a peak in terms of recommendations for supplementation with it. Some of the studies focus on the link between autoimmune diseases and nutritional deficiencies, especially vitamin D3. Since the specialized literature aimed at children (patients between 0-18 years old) is far from equal to the informational diversity of the adult-centered branch, this review aims to bring up to date the relationship between the microbial and nutritional balance and the activity of pediatric systemic lupus erythematosus (pSLE). The desired practical purpose resides in a better understanding and an adequate, individualized management of the affected persons to reduce morbidity. The center of the summary is to establish the impact of hypovitaminosis D in the development and evolution of pediatric lupus erythematosus. We will address aspects related to the two entities of the impact played by vitamin D3 in the pathophysiological cascade of lupus, but also the risk of toxicity and its effects when the deficiency is over supplemented (hypervitaminosis D). We will debate the relationship of hypovitaminosis D with the modulation of immune function, the potentiation of inflammatory processes, the increase of oxidative stress, the perfusion of cognitive brain areas, the seasonal incidence of SLE and its severity. Finally, we review current knowledge, post-pandemic, regarding the hypovitaminosis D - pSLE relationship.

Identifiants

pubmed: 38715605
doi: 10.3389/fimmu.2024.1373904
pmc: PMC11074404
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1373904

Informations de copyright

Copyright © 2024 Lupu, Lupu, Jechel, Starcea, Stoleriu, Ioniuc, Azoicai, Danielescu, Knieling, Borka-Balas, Salaru, Revenco and Fotea.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer COM declared a shared affiliation with the author RB to the handling editor at time of review.

Auteurs

Vasile Valeriu Lupu (VV)

Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Ancuta Lupu (A)

Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Elena Jechel (E)

Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Iuliana Magdalena Starcea (IM)

Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Gabriela Stoleriu (G)

Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, Galati, Romania.

Ileana Ioniuc (I)

Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Alice Azoicai (A)

Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Ciprian Danielescu (C)

Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Anton Knieling (A)

Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Reka Borka-Balas (R)

Pediatrics, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology, Targu Mures, Romania.

Delia Lidia Salaru (DL)

Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Ninel Revenco (N)

Pediatrics, "Nicolae Testemitanu" State University of Medicine and Pharmacy, Chisinau, Moldova.

Silvia Fotea (S)

Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, Galati, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH